Simeprevir with peginterferon α-2a/ribavirin for chronic hepatitis C virus genotype 1 infection in t...
Simeprevir with peginterferon α-2a/ribavirin for chronic hepatitis C virus genotype 1 infection in treatment-experienced patients: an open-label, rollover study
About this item
Full title
Author / Creator
Gane, Edward J. , DeJesus, Edwin , Janczewska, Ewa , George, Jacob , Diago, Moises , Da Silva, Mariliza Hendrique , Reesink, Henk , Nikitin, Igor , Hinrichsen, Holger , Bourgeois, Stefan , Ferenci, Peter , Shukla, Umesh , Kalmeijer, Ronald , Lenz, Oliver , Fevery, Bart , Corbett, Chris , Beumont, Maria and Jessner, Wolfgang
Publisher
England: BioMed Central
Journal title
Language
English
Formats
Publication information
Publisher
England: BioMed Central
Subjects
More information
Scope and Contents
Contents
This Phase 3, open-label, rollover study (NCT01323244) investigated the efficacy and safety of simeprevir plus peginterferon α-2a (PegIFNα-2a) and ribavirin (RBV) in a well-characterized population of HCV genotype 1 (GT1)-infected treatment-experienced patients.
Patients who had failed PegIFNα/RBV treatment in the placebo arm of a previous Phase...
Alternative Titles
Full title
Simeprevir with peginterferon α-2a/ribavirin for chronic hepatitis C virus genotype 1 infection in treatment-experienced patients: an open-label, rollover study
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_3cfa6244d4a94f6ba954c69bc057268c
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_3cfa6244d4a94f6ba954c69bc057268c
Other Identifiers
ISSN
1471-2334
E-ISSN
1471-2334
DOI
10.1186/s12879-017-2444-3
